Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Philadelphia region or Princeton Health.

within
I am searching for a
Reset Form
Caitlin S. Farabaugh, MD

Caitlin S. Farabaugh, MD Physician

Adjunct Assistant Professor of Obstetrics and Gynecology

Dr. Farabaugh is employed by or has a contract with Penn Medicine Lancaster General Health.

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine Lancaster General Health.

Overall Ratings

Clinical Specialties

Specialty:

  • Gynecologic Oncology

Board Certification:

  • Obstetrics and Gynecology - Gynecologic Oncology, 2017
  • Obstetrics and Gynecology, 2016

Clinical Expertise:

  • Cervical Cancer
  • Cervical Dysplasia
  • Endometrial Cancer
  • Fallopian Tube Cancer
  • Gynecologic Surgery
  • Leiomyosarcoma
  • Ovarian Cancer
  • Ovarian Tumors
  • Urethral Cancer
  • Uterine Cancer
  • Vaginal Cancer

Practice Locations and Appointments

Recent Writings

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Capital Blue Cross
  • Cigna
  • Cigna HealthSpring
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • Highmark Blue Shield
  • Highmark Blue Shield Medicare
  • Humana / Choicecare
  • Humana / Medicare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Multiplan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/PA Preferred Health Networks
  • Rail Road Medicare / Palmetto GBA
  • Significa Benefit Services (fka EHP)
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • UPMC Health Plan
  • Veterans Choice Program
  • Vibra Health Plan

Education and Training

Medical School: Dartmouth Medical School
Residency: University of Colorado Medical Center
Fellowship: Hospital of the University of Pennsylvania

Memberships

American College of Obstetricians and Gynecologists, National Society of Gynecologic Oncologists, National

Hospital Affiliation

Dr. Farabaugh is employed by or has a contract with Penn Medicine Lancaster General Health.

Hospital Privileges:

  • Lancaster General Hospital: Has privileges to treat patients in the hospital.

Research

Selected Publications:

Stashwick, Czernieck BJ, Tanyi JL: Dendritic Cell Vaccine Therapy for Ovarian Cancer Chapter. Ovarian Cancer Immunotherapy: Current Perspectives Chpt 8 : 2018.

O'Hara MH, Stashwick C, Plesa G, Tanyi JL: Overcoming barriers of car T-cell therapy in patients with mesothelin-expressing cancers. Immunotherapy 9(9):767-780 : 2017.

Tanyi JL, Stashwick C, Plesa G, Morgan MA, Porter D, Maus MV, June CH: Possible Compartmental Cytokine Release Syndrome in a Patient With Recurrent Ovarian Cancer After Treatment With Mesothelin-targeted CAR-T Cells. J Immunotherapy 40(3):104-107 : 2017.

Smith JB, Lanitis E, Dangaj D, Buza E, Poussin M, Stashwick C, Scholler N, Powell DJ Jr: Tumor regression and delayed onset toxicity following B7-H4 CAR T cell Therapy. Mol Ther 24(11):1987-1999 : 2016.

Dean LT, Zhang X, Latif N, Giuntoli R, Lin L, Haggerty A, Kim S, Shalowitz D, Stashwick C, Simpkins F, Burger R, Morgan M, Schmitz K: Race-based disparities in loss of functional independence after hysterectomy for uterine cancer. Support Care Cancer 24(8):3573-80 : 2016.

O’Hara M, Stashwick C, Haas AR, Tanyi JL: Mesothelin as a target for chimeric antigen receptor-modified T cells as anticancer therapy. Immunotherapy 8(4):449-60 : 2016.

Urbanksa K, Stashwick C, Powell DJ: Follicle-stimulating hormone receptor as a target in the redirected T-cell therapy for cancer. Cancer Immunology Research 3(10):1130-7 : 2015.

Urbanska K, Lynn R, Stashwick C, Thakur A, Lum L, Powell DJ: Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells. J Transl Med 13;12:347 : 2014.

Smith J*, Stashwick C*, Powell DJ (*co-first authors): B7-H4 as a potential target for immunotherapy for gynecologic cancer: A closer look. Gynecol Oncol 134(1):181-189 : 2014.

Stashwick C, Post MD, Arruda JS, Spillman, MA, Behbakht K, Davidson SA, Kelly MG: Surgical risk score predicts suboptimal debulking or a major perioperative complication in patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer. Int J Gynecol Cancer 21(8):1422-7 : 2011.

Academic Contact Info

Ann B Barshinger Cancer Institute
Lancaster General Health/Penn Medicine
2102 Harrisburg Pike

Lancaster, PA 17601
Phone: (617) 835-1405
Patient appointments: 800-789-7366 (PENN)